MDIT - Medite Cancer Diagnostics, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.22M
Enterprise Value 310.47M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.52
Price/Book (mrq)0.64
Enterprise Value/Revenue 31.29
Enterprise Value/EBITDA 6-2.81

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin -65.49%
Operating Margin (ttm)-49.34%

Management Effectiveness

Return on Assets (ttm)-13.68%
Return on Equity (ttm)-73.70%

Income Statement

Revenue (ttm)8.13M
Revenue Per Share (ttm)0.17
Quarterly Revenue Growth (yoy)42.00%
Gross Profit (ttm)162k
Net Income Avi to Common (ttm)-5.42M
Diluted EPS (ttm)-0.1100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)90k
Total Cash Per Share (mrq)0
Total Debt (mrq)6.05M
Total Debt/Equity (mrq)94.00
Current Ratio (mrq)1.11
Book Value Per Share (mrq)0.08

Cash Flow Statement

Operating Cash Flow (ttm)-5.19M
Levered Free Cash Flow (ttm)-2.44M

Trading Information

Stock Price History

Beta (3Y Monthly) 4.20
52-Week Change 3-67.33%
S&P500 52-Week Change 310.38%
52 Week High 30.4000
52 Week Low 30.0100
50-Day Moving Average 30.0306
200-Day Moving Average 30.0499

Share Statistics

Avg Vol (3 month) 31.06k
Avg Vol (10 day) 3100
Shares Outstanding 586.18M
Float 17.55M
% Held by Insiders 166.55%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2100/1
Last Split Date 3Mar 12, 2015